Rhythm Biosciences Limited (ASX:RHY)
Australia flag Australia · Delayed Price · Currency is AUD
0.0910
-0.0050 (-5.21%)
Sep 1, 2025, 4:10 PM AEST

Rhythm Biosciences Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2017 - 2020
Other Revenue
3.331.693.12.431.11
Upgrade
3.331.693.12.431.11
Upgrade
Revenue Growth (YoY)
96.80%-45.41%27.54%118.98%1008.51%
Upgrade
Cost of Revenue
0.223.05---
Upgrade
Gross Profit
3.1-1.363.12.431.11
Upgrade
Selling, General & Admin
5.1237.75.993.03
Upgrade
Research & Development
1.382.353.655.164.55
Upgrade
Operating Expenses
6.75.5511.5411.257.73
Upgrade
Operating Income
-3.6-6.91-8.44-8.82-6.62
Upgrade
Interest Expense
-0.07-0-0.01--0
Upgrade
Interest & Investment Income
-0.050.230.020.01
Upgrade
EBT Excluding Unusual Items
-3.66-6.86-8.22-8.79-6.61
Upgrade
Merger & Restructuring Charges
-0.17----
Upgrade
Pretax Income
-3.83-6.86-8.22-8.79-6.61
Upgrade
Net Income
-3.83-6.86-8.22-8.79-6.61
Upgrade
Net Income to Common
-3.83-6.86-8.22-8.79-6.61
Upgrade
Shares Outstanding (Basic)
270228217210185
Upgrade
Shares Outstanding (Diluted)
270228217210185
Upgrade
Shares Change (YoY)
18.12%5.26%3.31%13.35%83.84%
Upgrade
EPS (Basic)
-0.01-0.03-0.04-0.04-0.04
Upgrade
EPS (Diluted)
-0.01-0.03-0.04-0.04-0.04
Upgrade
Free Cash Flow
-2.94-6.22-7.06-6.52-5.47
Upgrade
Free Cash Flow Per Share
-0.01-0.03-0.03-0.03-0.03
Upgrade
Gross Margin
93.24%-80.31%100.00%100.00%100.00%
Upgrade
Operating Margin
-108.09%-408.60%-272.60%-363.29%-597.64%
Upgrade
Profit Margin
-115.13%-405.69%-265.44%-362.26%-596.49%
Upgrade
Free Cash Flow Margin
-88.52%-367.98%-227.94%-268.74%-493.52%
Upgrade
EBITDA
-3.4-6.8-8.34-8.72-6.52
Upgrade
EBITDA Margin
-102.17%--269.35%--
Upgrade
D&A For EBITDA
0.20.110.10.090.11
Upgrade
EBIT
-3.6-6.91-8.44-8.82-6.62
Upgrade
EBIT Margin
-108.09%--272.60%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.